3.83Open3.83Pre Close0 Volume1 Open Interest1.00Strike Price0.00Turnover762.95%IV2.55%PremiumDec 20, 2024Expiry Date3.71Intrinsic Value100Multiplier5DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type0.9828Delta0.0096Gamma1.26Leverage Ratio-0.0158Theta0.0001Rho1.23Eff Leverage0.0002Vega
Fortuna Silver Mines Stock Discussion
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet